Literature DB >> 8423855

Viral DNA and a viral peptide can act as cofactors of adenovirus virion proteinase activity.

W F Mangel1, W J McGrath, D L Toledo, C W Anderson.   

Abstract

Human adenovirus (Ad2), like many other viruses, contains a virion-associated proteinase essential for the synthesis of infectious virus particles. We observed proteinase activity in wild-type virus but not in the ts-1 virus, which contains a mutation in the Ad2 L3 endoprotease gene that confers temperature-sensitive processing of virion precursor proteins. Unexpectedly, we did not observe proteinase activity with purified recombinant endoprotease protein (M(r) 23 K). Purified recombinant endoprotease protein, however, complemented the mutation in ts-1 virions, restoring proteinase activity when mixed together. This implied that cofactors may be required. Here we reconstitute proteinase activity in vitro with three purified viral components: (1) the recombinant endoprotease protein; (2) an 11-amino-acid peptide that originates from the carboxy terminus of pVI, the precursor to virion component VI; and (3) adenovirus DNA. The use of DNA for a proteinase activity is unprecedented.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8423855     DOI: 10.1038/361274a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  63 in total

1.  Deubiquitinating function of adenovirus proteinase.

Authors:  Maxim Y Balakirev; Michel Jaquinod; Arthur L Haas; Jadwiga Chroboczek
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

2.  Polyprotein processing protease of African swine fever virus: purification and biochemical characterization.

Authors:  Daniel Rubio; Alí Alejo; Irene Rodríguez; María L Salas
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

3.  Switch from capsid protein import to adenovirus assembly by cleavage of nuclear transport signals.

Authors:  Harald Wodrich; Tinglu Guan; Gino Cingolani; Dan Von Seggern; Glen Nemerow; Larry Gerace
Journal:  EMBO J       Date:  2003-12-01       Impact factor: 11.598

4.  Functional genetic and biophysical analyses of membrane disruption by human adenovirus.

Authors:  Crystal L Moyer; Christopher M Wiethoff; Oana Maier; Jason G Smith; Glen R Nemerow
Journal:  J Virol       Date:  2011-01-05       Impact factor: 5.103

5.  A Single Maturation Cleavage Site in Adenovirus Impacts Cell Entry and Capsid Assembly.

Authors:  Crystal L Moyer; Eli S Besser; Glen R Nemerow
Journal:  J Virol       Date:  2015-10-21       Impact factor: 5.103

6.  Adenovirus protein VI mediates membrane disruption following capsid disassembly.

Authors:  Christopher M Wiethoff; Harald Wodrich; Larry Gerace; Glen R Nemerow
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

7.  Processing of the l1 52/55k protein by the adenovirus protease: a new substrate and new insights into virion maturation.

Authors:  Ana J Pérez-Berná; Walter F Mangel; William J McGrath; Vito Graziano; Jane Flint; Carmen San Martín
Journal:  J Virol       Date:  2013-11-13       Impact factor: 5.103

8.  Activity, specificity, and probe design for the smallpox virus protease K7L.

Authors:  Alexander E Aleshin; Marcin Drag; Naran Gombosuren; Ge Wei; Jowita Mikolajczyk; Arnold C Satterthwait; Alex Y Strongin; Robert C Liddington; Guy S Salvesen
Journal:  J Biol Chem       Date:  2012-09-25       Impact factor: 5.157

9.  Dynamic competition for hexon binding between core protein VII and lytic protein VI promotes adenovirus maturation and entry.

Authors:  Mercedes Hernando-Pérez; Natalia Martín-González; Marta Pérez-Illana; Maarit Suomalainen; Gabriela N Condezo; Philomena Ostapchuk; José Gallardo; Margarita Menéndez; Urs F Greber; Patrick Hearing; Pedro J de Pablo; Carmen San Martín
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-28       Impact factor: 11.205

10.  Identification of active-site residues of the adenovirus endopeptidase.

Authors:  C Rancourt; K Tihanyi; M Bourbonniere; J M Weber
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.